​Evaluators are increasingly asked to evaluate programs and policies to address emerging public health issues, such as prescription drug overdose. These highly visible and pressing problems call for a rapid scale-up of initiatives. Evaluators are often under pressure to provide data and evaluation findings to fit a range of stakeholders for a variety of purposes. Evaluators often use a set of tools to engage stakeholders, like sense making and other participatory practices, to interpret evaluation data and determine findings to meet their needs. This presentation will highlight evaluation efforts in three states, funded by the Centers for Disease Control and Preventions’ Prescription Drug Overdose Prevention for States program. In each presentation the evaluators will describe how they engaged their stakeholders to interpret evaluation data and tailor findings to inform a variety of stakeholder needs. State evaluators will highlight their successes, barriers, and lessons learned throughout this process.